Previous 10 | Next 10 |
Orthofix (NASDAQ: OFIX ): Q3 Non-GAAP EPS of $0.41 misses by $0.10 ; GAAP EPS of -$2.14 misses by $2.37 . More news on: Orthofix Medical Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Jon Serbousek to succeed Brad Mason as President and Chief Executive Officer on November 1, 2019 Net sales of $113.5 million, an increase of 1.6% compared to prior year and 2.5% on a constant currency basis Biologics tissue services fees increased 11.4%, its second consec...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the third quarter 2019 after market close on Monday, October 28, 2019. Brad Mason, President and Chief Executi...
Orthofix Medical, Inc. (OFIX) Q2 2019 Earnings Conference Call August 05, 2019, 16:30 ET Company Participants Mark Quick - Director, IR Bradley Mason - President, CEO & Director Douglas Rice - CFO & CAO Conference Call Participants Craig Bijou - Cantor Fitzgerald &a...
Orthofix (NASDAQ: OFIX ): Q2 Non-GAAP EPS of $0.28 misses by $0.14 ; GAAP EPS of -$0.03 misses by $0.19 . More news on: Orthofix Medical Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
- Serbousek to succeed Brad Mason upon his retirement on October 31, 2019 - Prior to assuming CEO role, Serbousek will serve as President of Global Spine Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today a...
Jon Serbousek to succeed Brad Mason as President and Chief Executive Officer on November 1, 2019 Net sales of $115.9 million, an increase of 3.9% compared to prior year and 5.0% on a constant currency basis Biologics products net sales increased 14.2% and now has #1 marke...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the second quarter 2019 after market close on Monday, August 5, 2019. Brad Mason, President and Chief Executiv...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that President and Chief Executive Officer Brad Mason will present at the Jefferies 2019 Healthcare Conference in New York on Thursday, June 6, 2019 at 1:30...
Quick Take Medtronic ( MDT ) announced it has agreed to acquire Titan Spine for an undisclosed amount. Titan Spine has developed titanium spine interbody implant and surface technologies. With the deal, MDT gains surface enhanced technologies that it can use for expanding its product l...
News, Short Squeeze, Breakout and More Instantly...
Orthofix Medical Inc. Company Name:
OFIX Stock Symbol:
NASDAQ Market:
Orthofix Medical Inc. Website:
Wednesday, August 14, 2024 at 2:30 pm Eastern Time Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in Canaccord Genuity's 44th Annual Growth Conference in Boston. Management is scheduled to pre...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716004...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510(k) clearance and first U.S. implant of the Fitbone ™ Transport and Lengthening System. Used to treat large bone defects in the femur and tibia due to trauma, infectious or ma...